Garmy-Susini Barbara, Jin Hui, Zhu Yuhong, Sung Rou-Jia, Hwang Rosa, Varner Judy
John and Rebecca Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, California 92093-0912, USA.
J Clin Invest. 2005 Jun;115(6):1542-51. doi: 10.1172/JCI23445. Epub 2005 May 2.
Neovascularization depends on vascular cell proliferation and on the stabilization of vessels by association of vascular smooth muscle-like pericytes with ECs. Here we show that integrin alpha4beta1 (VLA-4) and VCAM-1 promote close intercellular adhesion between ECs and pericytes and that this interaction is required for blood vessel formation. Integrin alpha4beta1 is expressed by proliferating but not quiescent ECs, while its ligand VCAM-1 is expressed by proliferating but not quiescent mural cells. Antagonists of this integrin-ligand pair block the adhesion of mural cells to proliferating endothelia in vitro and in vivo, thereby inducing apoptosis of ECs and pericytes and inhibiting neovascularization. These studies indicate that integrin alpha4beta1 and VCAM-1 facilitate a critical cell-cell adhesion event required for survival of endothelial and mural cells during vascularization.
血管生成依赖于血管细胞的增殖以及血管平滑肌样周细胞与内皮细胞结合对血管的稳定作用。在此我们表明,整合素α4β1(VLA-4)和血管细胞黏附分子-1(VCAM-1)促进内皮细胞与周细胞之间紧密的细胞间黏附,且这种相互作用是血管形成所必需的。整合素α4β1由增殖的而非静止的内皮细胞表达,而其配体VCAM-1由增殖的而非静止的壁细胞表达。这一整合素-配体对的拮抗剂在体外和体内均可阻断壁细胞与增殖内皮细胞的黏附,从而诱导内皮细胞和周细胞凋亡并抑制血管生成。这些研究表明,整合素α4β1和VCAM-1促进了血管生成过程中内皮细胞和壁细胞存活所需的关键细胞间黏附事件。